Skip to content

Evaluation of pre-treatment of additional water-supplementation in order to induce the sufficient effects of Moviprep

Evaluation of pre-treatment of additional water-supplementation in order to induce the sufficient effects of Moviprep - Additional water supplementation effects in the use of Moviprep

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015163
Enrollment
30
Registered
2014-10-01
Start date
2014-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The purpose of this study is to induce the sufficient effects of Moviprep by comparison with or wothout water-supplementation

Interventions

water-supplementation without water-supplementation

Sponsors

Saitama Medical Center, Saitama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are tolerated to colonoscopy and Moviprep preparation. Patients who has informed consents. Patients whose age are 18 and more.

Exclusion criteria

Exclusion criteria: Patients who have or who are suspected to have gastrointestinal obstruction. Patients who has intestinal perforation. Patients who has delayed outlet of stomach. Patients who has toxic megacolon. Patients who allergy of Moviprep. Patients who are not suitable to this study.

Design outcomes

Primary

MeasureTime frame
cleansing effects of large bowel for the colonoscop including of total laxative volume, preparation time, endoscopic evaluation

Secondary

MeasureTime frame
Urinary osmotic pressure and specific gravity, patients' tolerability and safety

Countries

Japan

Contacts

Public ContactShingo Kato

Saitama Medical Center, Saitama Medical University Gastroenterology and hepatology

skato@saitama-med.ac.jp049-228-3564

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026